Literature DB >> 10417488

Spontaneous reporting--of what? Clinical concerns about drugs.

I R Edwards1.   

Abstract

Mesh：

Year:  1999        PMID： 10417488      PMCID： PMC2014296          DOI： 10.1046/j.1365-2125.1999.00000.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  13 in total

1.  Reasons for reporting adverse drug reactions--some thoughts based on an international review.

Authors:  C Biriell; I R Edwards
Journal:  Pharmacoepidemiol Drug Saf       Date:  1997-01       Impact factor: 2.890

2.  The New Zealand Intensive Medicines Monitoring Programme.

Authors:  D M Coulter
Journal:  Pharmacoepidemiol Drug Saf       Date:  1998-03       Impact factor: 2.890

3.  The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II.

Authors:  L L Leape; T A Brennan; N Laird; A G Lawthers; A R Localio; B A Barnes; L Hebert; J P Newhouse; P C Weiler; H Hiatt
Journal:  N Engl J Med       Date:  1991-02-07       Impact factor: 91.245

4.  Quality criteria for early signals of possible adverse drug reactions.

Authors:  I R Edwards; M Lindquist; B E Wiholm; E Napke
Journal:  Lancet       Date:  1990-07-21       Impact factor: 79.321

Review 5.  Principles of signal detection in pharmacovigilance.

Authors:  R H Meyboom; A C Egberts; I R Edwards; Y A Hekster; F H de Koning; F W Gribnau
Journal:  Drug Saf       Date:  1997-06       Impact factor: 5.606

6.  Who cares about pharmacovigilance?

Authors:  I R Edwards
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

7.  Reporting of adverse drug reactions by hospital pharmacists: pilot scheme.

Authors:  A Lee; D N Bateman; C Edwards; J M Smith; M D Rawlins
Journal:  BMJ       Date:  1997-08-30

8.  Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. The European Pharmacovigilance Research Group.

Authors:  K J Belton
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

9.  Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.

Authors:  J Lazarou; B H Pomeranz; P N Corey
Journal:  JAMA       Date:  1998-04-15       Impact factor: 56.272

10.  Adverse drug reaction monitoring: doing it the French way.

Authors:  N Moore; M Biour; G Paux; E Loupi; B Begaud; F Boismare; R J Royer
Journal:  Lancet       Date:  1985-11-09       Impact factor: 79.321
View more
  16 in total

1.  Adverse drug reactions: analysis of spontaneous reporting system in Europe in 2007-2009.

Authors:  Jindrich Srba; Veronika Descikova; Jiri Vlcek
Journal:  Eur J Clin Pharmacol       Date:  2012-02-01       Impact factor: 2.953

2.  Controlled trials and risk of harm.

Authors:  I Ralph Edwards
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 3.  Can Disproportionality Analysis of Post-marketing Case Reports be Used for Comparison of Drug Safety Profiles?

Authors:  Christiane Michel; Emil Scosyrev; Michael Petrin; Robert Schmouder
Journal:  Clin Drug Investig       Date:  2017-05       Impact factor: 2.859

4.  Data Mining for Adverse Drug Events With a Propensity Score-matched Tree-based Scan Statistic.

Authors:  Shirley V Wang; Judith C Maro; Elande Baro; Rima Izem; Inna Dashevsky; James R Rogers; Michael Nguyen; Joshua J Gagne; Elisabetta Patorno; Krista F Huybrechts; Jacqueline M Major; Esther Zhou; Megan Reidy; Austin Cosgrove; Sebastian Schneeweiss; Martin Kulldorff
Journal:  Epidemiology       Date:  2018-11       Impact factor: 4.822

5.  The hope, hype and reality of Big Data for pharmacovigilance.

Authors:  Andrew Bate; Robert F Reynolds; Patrick Caubel
Journal:  Ther Adv Drug Saf       Date:  2017-10-31

6.  Adverse drug reactions related to the use of NSAIDs with a focus on nimesulide: results of spontaneous reporting from a Northern Italian area.

Authors:  A Conforti; R Leone; U Moretti; F Mozzo; G Velo
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 7.  Consumer adverse drug reaction reporting: a new step in pharmacovigilance?

Authors:  Kees van Grootheest; Linda de Graaf; Lolkje T W de Jong-van den Berg
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

8.  Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regions.

Authors:  Roberto Leone; Mauro Venegoni; Domenico Motola; Ugo Moretti; Valentina Piazzetta; Alfredo Cocci; Domenico Resi; Federico Mozzo; Giampaolo Velo; Liliana Burzilleri; Nicola Montanaro; Anita Conforti
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 9.  Pharmacovigilance: methods, recent developments and future perspectives.

Authors:  L Härmark; A C van Grootheest
Journal:  Eur J Clin Pharmacol       Date:  2008-06-04       Impact factor: 2.953

10.  Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example.

Authors:  Florence van Hunsel; Anneke Passier; Kees van Grootheest
Journal:  Br J Clin Pharmacol       Date:  2009-02-26       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.